

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.19816436 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 4.15835733 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.95797598 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.95797598 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 3.95797598 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.95797598 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 3.95797598 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.95797598 |
| 9 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.75919142 |
| 10 | protein localization to endosome (GO:0036010) | 3.63465949 |
| 11 | cellular extravasation (GO:0045123) | 3.61400474 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59523258 |
| 13 | sodium ion export (GO:0071436) | 3.56951660 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47482045 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.40069907 |
| 16 | regulation of ARF protein signal transduction (GO:0032012) | 3.35321382 |
| 17 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.33854712 |
| 18 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.33154825 |
| 19 | detection of other organism (GO:0098543) | 3.28097248 |
| 20 | microglial cell activation (GO:0001774) | 3.27902662 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24514836 |
| 22 | protein targeting to Golgi (GO:0000042) | 3.20027023 |
| 23 | positive regulation of mast cell activation (GO:0033005) | 3.14916872 |
| 24 | regulation of meiosis I (GO:0060631) | 3.14502601 |
| 25 | establishment of protein localization to Golgi (GO:0072600) | 3.11422768 |
| 26 | detection of external biotic stimulus (GO:0098581) | 3.08499689 |
| 27 | neutrophil mediated immunity (GO:0002446) | 3.07932773 |
| 28 | positive regulation of macrophage cytokine production (GO:0060907) | 3.06368568 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01910925 |
| 30 | macroautophagy (GO:0016236) | 2.98388155 |
| 31 | early endosome to late endosome transport (GO:0045022) | 2.95202104 |
| 32 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.95152243 |
| 33 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93831591 |
| 34 | Rap protein signal transduction (GO:0032486) | 2.92079536 |
| 35 | synaptic vesicle maturation (GO:0016188) | 2.91876082 |
| 36 | response to peptidoglycan (GO:0032494) | 2.91422164 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 2.91172874 |
| 38 | positive regulation of mast cell degranulation (GO:0043306) | 2.90985449 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90985449 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 2.90133860 |
| 41 | growth hormone receptor signaling pathway (GO:0060396) | 2.87955303 |
| 42 | Golgi to endosome transport (GO:0006895) | 2.87917009 |
| 43 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.87846305 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 2.84493354 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 2.83442410 |
| 46 | response to host immune response (GO:0052572) | 2.82911151 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82911151 |
| 48 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.78599696 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78095311 |
| 50 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.76955184 |
| 51 | macrophage activation (GO:0042116) | 2.76651259 |
| 52 | positive regulation of histone deacetylation (GO:0031065) | 2.75957177 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74253840 |
| 54 | response to hydroperoxide (GO:0033194) | 2.71878352 |
| 55 | detection of biotic stimulus (GO:0009595) | 2.71773882 |
| 56 | interferon-gamma production (GO:0032609) | 2.71067234 |
| 57 | plasma membrane repair (GO:0001778) | 2.70444031 |
| 58 | interkinetic nuclear migration (GO:0022027) | 2.67558286 |
| 59 | histone H3-K36 demethylation (GO:0070544) | 2.67050955 |
| 60 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66073985 |
| 61 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64884426 |
| 62 | cellular response to ethanol (GO:0071361) | 2.64433546 |
| 63 | N-acetylneuraminate metabolic process (GO:0006054) | 2.63770894 |
| 64 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.63180977 |
| 65 | piRNA metabolic process (GO:0034587) | 2.61130258 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.59564842 |
| 67 | regulation of mast cell activation (GO:0033003) | 2.59375622 |
| 68 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.58542577 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 2.58367419 |
| 70 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.56899441 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.56509184 |
| 72 | activation of protein kinase A activity (GO:0034199) | 2.56482237 |
| 73 | regulation of Rap GTPase activity (GO:0032317) | 2.55396412 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55200767 |
| 75 | regulation of establishment of cell polarity (GO:2000114) | 2.55093640 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54244099 |
| 77 | response to host (GO:0075136) | 2.53060805 |
| 78 | response to host defenses (GO:0052200) | 2.53060805 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53060805 |
| 80 | positive regulation of regulated secretory pathway (GO:1903307) | 2.51155100 |
| 81 | germinal center formation (GO:0002467) | 2.50989846 |
| 82 | cellular response to growth hormone stimulus (GO:0071378) | 2.50974490 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 2.50626825 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50447789 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49352156 |
| 86 | proline transport (GO:0015824) | 2.47781575 |
| 87 | regulation of interferon-alpha production (GO:0032647) | 2.47333406 |
| 88 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.46519529 |
| 89 | locomotory exploration behavior (GO:0035641) | 2.45194950 |
| 90 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.44524775 |
| 91 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.43571341 |
| 92 | negative regulation of interleukin-17 production (GO:0032700) | 2.43193257 |
| 93 | negative regulation of B cell mediated immunity (GO:0002713) | 2.42010857 |
| 94 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.42010857 |
| 95 | myeloid cell activation involved in immune response (GO:0002275) | 2.41359457 |
| 96 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.41300327 |
| 97 | potassium ion import (GO:0010107) | 2.40557181 |
| 98 | regulation of mast cell degranulation (GO:0043304) | 2.40100693 |
| 99 | detection of bacterium (GO:0016045) | 2.40004583 |
| 100 | vesicle transport along microtubule (GO:0047496) | 2.38969290 |
| 101 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.37739466 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37418119 |
| 103 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37418119 |
| 104 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.37031961 |
| 105 | positive regulation of vesicle fusion (GO:0031340) | 2.36359442 |
| 106 | thyroid hormone metabolic process (GO:0042403) | 2.36245104 |
| 107 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.34892365 |
| 108 | negative regulation of adaptive immune response (GO:0002820) | 2.34849427 |
| 109 | regulation of protein glycosylation (GO:0060049) | 2.34442340 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 2.33212574 |
| 111 | regulation of germinal center formation (GO:0002634) | 2.32798295 |
| 112 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30422471 |
| 113 | hemidesmosome assembly (GO:0031581) | 2.29551341 |
| 114 | regulation of regulated secretory pathway (GO:1903305) | 2.28732202 |
| 115 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.28701657 |
| 116 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.28701657 |
| 117 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.28701657 |
| 118 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.28449947 |
| 119 | cellular sodium ion homeostasis (GO:0006883) | 2.28297537 |
| 120 | positive regulation of interferon-beta production (GO:0032728) | 2.28281664 |
| 121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.27575278 |
| 122 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.26018776 |
| 123 | cell adhesion mediated by integrin (GO:0033627) | 2.25789887 |
| 124 | relaxation of cardiac muscle (GO:0055119) | 2.25314803 |
| 125 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.24158325 |
| 126 | phospholipid homeostasis (GO:0055091) | 2.21410705 |
| 127 | alanine transport (GO:0032328) | 2.20332260 |
| 128 | alpha-linolenic acid metabolic process (GO:0036109) | 2.19880560 |
| 129 | positive regulation of glycolytic process (GO:0045821) | 2.19718370 |
| 130 | lipid translocation (GO:0034204) | 2.18103966 |
| 131 | phospholipid translocation (GO:0045332) | 2.18103966 |
| 132 | apoptotic cell clearance (GO:0043277) | 2.17715464 |
| 133 | layer formation in cerebral cortex (GO:0021819) | 2.17039640 |
| 134 | * endoplasmic reticulum organization (GO:0007029) | 2.16447371 |
| 135 | negative regulation of cell size (GO:0045792) | 2.14847849 |
| 136 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.14335718 |
| 137 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.13409283 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.12804729 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.12640340 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.12640340 |
| 141 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.11476748 |
| 142 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.11431898 |
| 143 | negative regulation of hormone metabolic process (GO:0032351) | 2.11431898 |
| 144 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.10701401 |
| 145 | fatty acid transmembrane transport (GO:1902001) | 2.10629612 |
| 146 | stress fiber assembly (GO:0043149) | 2.10214496 |
| 147 | peptidyl-lysine dimethylation (GO:0018027) | 2.09329958 |
| 148 | regulation of p38MAPK cascade (GO:1900744) | 2.08992594 |
| 149 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.07831398 |
| 150 | histone H3-K9 demethylation (GO:0033169) | 2.06351392 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 2.05321709 |
| 152 | cell communication by electrical coupling (GO:0010644) | 2.04567114 |
| 153 | regulation of ARF GTPase activity (GO:0032312) | 2.04388588 |
| 154 | Golgi transport vesicle coating (GO:0048200) | 2.03376153 |
| 155 | COPI coating of Golgi vesicle (GO:0048205) | 2.03376153 |
| 156 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.02867290 |
| 157 | urea metabolic process (GO:0019627) | 2.02438222 |
| 158 | urea cycle (GO:0000050) | 2.02438222 |
| 159 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.01700341 |
| 160 | establishment of nucleus localization (GO:0040023) | 2.00795050 |
| 161 | peptidyl-threonine modification (GO:0018210) | 2.00636752 |
| 162 | peptidyl-threonine phosphorylation (GO:0018107) | 2.00494765 |
| 163 | negative regulation of fatty acid transport (GO:2000192) | 1.99575451 |
| 164 | lysine metabolic process (GO:0006553) | 1.99562764 |
| 165 | lysine catabolic process (GO:0006554) | 1.99562764 |
| 166 | NLS-bearing protein import into nucleus (GO:0006607) | 1.99258356 |
| 167 | regulation of protein polyubiquitination (GO:1902914) | 1.98977613 |
| 168 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.98290902 |
| 169 | carnitine shuttle (GO:0006853) | 1.98283025 |
| 170 | negative regulation of lipid transport (GO:0032369) | 1.96799433 |
| 171 | clathrin coat assembly (GO:0048268) | 1.96353501 |
| 172 | lipoprotein transport (GO:0042953) | 1.96271518 |
| 173 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.95980844 |
| 174 | cell communication involved in cardiac conduction (GO:0086065) | 1.95806946 |
| 175 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.94931931 |
| 176 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.94808398 |
| 177 | protein carboxylation (GO:0018214) | 1.94808398 |
| 178 | phospholipid dephosphorylation (GO:0046839) | 1.94753916 |
| 179 | positive regulation of Rap GTPase activity (GO:0032854) | 1.94708711 |
| 180 | regulation of Rac protein signal transduction (GO:0035020) | 1.94031353 |
| 181 | glutamate metabolic process (GO:0006536) | 1.93271572 |
| 182 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.92669734 |
| 183 | receptor catabolic process (GO:0032801) | 1.91372951 |
| 184 | phosphatidylinositol dephosphorylation (GO:0046856) | 1.89869345 |
| 185 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.89685897 |
| 186 | protein targeting to plasma membrane (GO:0072661) | 1.89652482 |
| 187 | cell-substrate junction assembly (GO:0007044) | 1.89219768 |
| 188 | nerve growth factor signaling pathway (GO:0038180) | 1.87505733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26764501 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.79272985 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.58205632 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25194522 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24363857 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22443121 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13334160 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.12312477 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02908916 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96757406 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93952136 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88446413 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86374416 |
| 14 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77527868 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76696295 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76295419 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75904681 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.75644566 |
| 19 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73273937 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71730222 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.70213074 |
| 22 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69655779 |
| 23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.68647409 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68193194 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64982627 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64361346 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61980626 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59128128 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59044063 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58007444 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55132656 |
| 32 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.53085846 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51625468 |
| 34 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.51141246 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49146788 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49027323 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48681433 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46830969 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46805524 |
| 40 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.46021808 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45010492 |
| 42 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.44558409 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43973561 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42952423 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42867000 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42391116 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41611520 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39243659 |
| 49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.38365085 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37835717 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37237245 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36680020 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34954172 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34433149 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34015091 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31698391 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31402334 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30890861 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29163978 |
| 60 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.28399927 |
| 61 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27148510 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26705102 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26705102 |
| 64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26277612 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25522596 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24953710 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24561711 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23781020 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22463331 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22347018 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21956978 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21917199 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21782170 |
| 74 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21719376 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21684923 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21120317 |
| 77 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20892338 |
| 78 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20680991 |
| 79 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20254333 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.19554567 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18998340 |
| 82 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18575100 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18312783 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18200588 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18106027 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17821773 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17759446 |
| 88 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17575331 |
| 89 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17292051 |
| 90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16527712 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16197104 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15106578 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14890126 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14584883 |
| 95 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13436569 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13067469 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12840446 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12762259 |
| 99 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12292826 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12239918 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11739816 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10957967 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10868017 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10817144 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10790968 |
| 106 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10732478 |
| 107 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10463896 |
| 108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09515259 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09218891 |
| 110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09059957 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08898518 |
| 112 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08666326 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08355115 |
| 114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08099455 |
| 115 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07932029 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07791658 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07029211 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06801610 |
| 119 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06772973 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06125644 |
| 121 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.05948873 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05782050 |
| 123 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05478482 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05395838 |
| 125 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04894679 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04136442 |
| 127 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03170101 |
| 128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02183761 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02147709 |
| 130 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02052143 |
| 131 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02052143 |
| 132 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01812183 |
| 133 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01767130 |
| 134 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01674226 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01623018 |
| 136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01605758 |
| 137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01039685 |
| 138 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00684037 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00076434 |
| 140 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97574470 |
| 141 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96826286 |
| 142 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96621934 |
| 143 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96174079 |
| 144 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.96023724 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95331633 |
| 146 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95033198 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94544650 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94259902 |
| 149 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94259902 |
| 150 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94168241 |
| 151 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93615395 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93611938 |
| 153 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93255345 |
| 154 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93081662 |
| 155 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92552333 |
| 156 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92193188 |
| 157 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91737631 |
| 158 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91459594 |
| 159 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91432157 |
| 160 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90455871 |
| 161 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89215061 |
| 162 | AR_19668381_ChIP-Seq_PC3_Human | 0.89201287 |
| 163 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88853799 |
| 164 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88213504 |
| 165 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.87816169 |
| 166 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87262540 |
| 167 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85894505 |
| 168 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.85632715 |
| 169 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85558975 |
| 170 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84901001 |
| 171 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84357566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 3.65024000 |
| 2 | MP0003724_increased_susceptibility_to | 3.60747761 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.57177294 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.44050354 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.37125738 |
| 6 | MP0008877_abnormal_DNA_methylation | 2.99202091 |
| 7 | MP0003787_abnormal_imprinting | 2.81835371 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.75449802 |
| 9 | MP0003890_abnormal_embryonic-extraembry | 2.73128990 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.70779115 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.62076766 |
| 12 | MP0005360_urolithiasis | 2.61664380 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.55747816 |
| 14 | MP0003252_abnormal_bile_duct | 2.48603453 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.45634424 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.42301791 |
| 17 | MP0004130_abnormal_muscle_cell | 2.39468875 |
| 18 | MP0003828_pulmonary_edema | 2.35838989 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.31272354 |
| 20 | MP0005365_abnormal_bile_salt | 2.29904246 |
| 21 | MP0003303_peritoneal_inflammation | 2.27564421 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 2.19632347 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.19130650 |
| 24 | MP0008057_abnormal_DNA_replication | 2.16991708 |
| 25 | MP0000372_irregular_coat_pigmentation | 2.05629388 |
| 26 | MP0003045_fibrosis | 2.01975274 |
| 27 | MP0006082_CNS_inflammation | 1.97499662 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 1.94804421 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.93196405 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.81686798 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.81130850 |
| 32 | MP0002419_abnormal_innate_immunity | 1.80375032 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.77711910 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.76406024 |
| 35 | MP0003136_yellow_coat_color | 1.76384618 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.72481203 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.69472678 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.68512594 |
| 39 | MP0005310_abnormal_salivary_gland | 1.64599930 |
| 40 | MP0000371_diluted_coat_color | 1.58051356 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.57180596 |
| 42 | MP0008004_abnormal_stomach_pH | 1.57142275 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.56027539 |
| 44 | MP0001790_abnormal_immune_system | 1.53136696 |
| 45 | MP0005387_immune_system_phenotype | 1.53136696 |
| 46 | MP0005409_darkened_coat_color | 1.51871673 |
| 47 | MP0000604_amyloidosis | 1.51245569 |
| 48 | MP0003436_decreased_susceptibility_to | 1.50139077 |
| 49 | MP0004381_abnormal_hair_follicle | 1.46142718 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.44328981 |
| 51 | MP0005187_abnormal_penis_morphology | 1.42505703 |
| 52 | MP0003880_abnormal_central_pattern | 1.40501876 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.37770029 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.35295274 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.35128814 |
| 56 | MP0000685_abnormal_immune_system | 1.33366178 |
| 57 | MP0003091_abnormal_cell_migration | 1.31131974 |
| 58 | MP0008260_abnormal_autophagy | 1.30780680 |
| 59 | MP0001800_abnormal_humoral_immune | 1.29384646 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.28363463 |
| 61 | MP0004510_myositis | 1.27711937 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.26633444 |
| 63 | MP0001984_abnormal_olfaction | 1.26455626 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.26139532 |
| 65 | MP0000609_abnormal_liver_physiology | 1.24993354 |
| 66 | MP0004883_abnormal_blood_vessel | 1.24754499 |
| 67 | MP0005083_abnormal_biliary_tract | 1.21817105 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.21658985 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.20739311 |
| 70 | MP0003868_abnormal_feces_composition | 1.20236870 |
| 71 | MP0003646_muscle_fatigue | 1.18733921 |
| 72 | MP0003329_amyloid_beta_deposits | 1.17048085 |
| 73 | MP0009115_abnormal_fat_cell | 1.16981974 |
| 74 | MP0000383_abnormal_hair_follicle | 1.16928504 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.16363324 |
| 76 | MP0000747_muscle_weakness | 1.13793725 |
| 77 | * MP0002118_abnormal_lipid_homeostasis | 1.13646802 |
| 78 | MP0002133_abnormal_respiratory_system | 1.13447115 |
| 79 | MP0005388_respiratory_system_phenotype | 1.13447115 |
| 80 | MP0004858_abnormal_nervous_system | 1.12980468 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.12964933 |
| 82 | MP0005408_hypopigmentation | 1.11005294 |
| 83 | MP0003075_altered_response_to | 1.09025947 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.08674999 |
| 85 | MP0001485_abnormal_pinna_reflex | 1.08290940 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 1.06701063 |
| 87 | MP0002928_abnormal_bile_duct | 1.06304971 |
| 88 | MP0006054_spinal_hemorrhage | 1.04659956 |
| 89 | MP0005000_abnormal_immune_tolerance | 1.03901833 |
| 90 | MP0009840_abnormal_foam_cell | 1.03603005 |
| 91 | MP0001299_abnormal_eye_distance/ | 1.03169577 |
| 92 | MP0002723_abnormal_immune_serum | 1.03166336 |
| 93 | MP0002095_abnormal_skin_pigmentation | 1.03164940 |
| 94 | MP0002971_abnormal_brown_adipose | 1.03079800 |
| 95 | MP0002332_abnormal_exercise_endurance | 1.01661337 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.01480298 |
| 97 | MP0001177_atelectasis | 1.00853236 |
| 98 | MP0010368_abnormal_lymphatic_system | 1.00710686 |
| 99 | MP0004947_skin_inflammation | 1.00430471 |
| 100 | MP0002148_abnormal_hypersensitivity_rea | 1.00412885 |
| 101 | MP0000920_abnormal_myelination | 1.00157069 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.98215966 |
| 103 | MP0003635_abnormal_synaptic_transmissio | 0.97923750 |
| 104 | MP0004270_analgesia | 0.97866128 |
| 105 | MP0002420_abnormal_adaptive_immunity | 0.97402338 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.97254069 |
| 107 | MP0004036_abnormal_muscle_relaxation | 0.97053231 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.96943986 |
| 109 | MP0001819_abnormal_immune_cell | 0.96708378 |
| 110 | MP0001486_abnormal_startle_reflex | 0.96366224 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.95555640 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.95555640 |
| 113 | MP0009046_muscle_twitch | 0.95487978 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.95116661 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.95059502 |
| 116 | MP0000427_abnormal_hair_cycle | 0.94473222 |
| 117 | MP0004087_abnormal_muscle_fiber | 0.93991902 |
| 118 | MP0002254_reproductive_system_inflammat | 0.93949020 |
| 119 | MP0003690_abnormal_glial_cell | 0.93527964 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.92736969 |
| 121 | MP0001849_ear_inflammation | 0.92569048 |
| 122 | MP0005535_abnormal_body_temperature | 0.91897513 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.91711737 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.91392052 |
| 125 | MP0002168_other_aberrant_phenotype | 0.91087059 |
| 126 | MP0005025_abnormal_response_to | 0.91083148 |
| 127 | MP0003011_delayed_dark_adaptation | 0.89717941 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.89606083 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.89510790 |
| 130 | MP0003633_abnormal_nervous_system | 0.89262693 |
| 131 | MP0010307_abnormal_tumor_latency | 0.89154149 |
| 132 | MP0005332_abnormal_amino_acid | 0.88903840 |
| 133 | MP0005171_absent_coat_pigmentation | 0.88780864 |
| 134 | MP0005164_abnormal_response_to | 0.86839897 |
| 135 | MP0005166_decreased_susceptibility_to | 0.86651694 |
| 136 | MP0005647_abnormal_sex_gland | 0.83634902 |
| 137 | MP0002090_abnormal_vision | 0.83427853 |
| 138 | MP0003283_abnormal_digestive_organ | 0.83315431 |
| 139 | MP0003632_abnormal_nervous_system | 0.82760506 |
| 140 | MP0001944_abnormal_pancreas_morphology | 0.82751271 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.81801614 |
| 142 | MP0005377_hearing/vestibular/ear_phenot | 0.81735095 |
| 143 | MP0003878_abnormal_ear_physiology | 0.81735095 |
| 144 | MP0002229_neurodegeneration | 0.81599210 |
| 145 | MP0002269_muscular_atrophy | 0.80493313 |
| 146 | MP0004484_altered_response_of | 0.79282963 |
| 147 | MP0003631_nervous_system_phenotype | 0.77374699 |
| 148 | MP0009785_altered_susceptibility_to | 0.77244580 |
| 149 | MP0005275_abnormal_skin_tensile | 0.76826189 |
| 150 | MP0002693_abnormal_pancreas_physiology | 0.76794799 |
| 151 | MP0005334_abnormal_fat_pad | 0.76512874 |
| 152 | MP0000465_gastrointestinal_hemorrhage | 0.76258013 |
| 153 | MP0000751_myopathy | 0.75894465 |
| 154 | MP0008874_decreased_physiological_sensi | 0.75740669 |
| 155 | MP0002009_preneoplasia | 0.75738064 |
| 156 | MP0000733_abnormal_muscle_development | 0.75182061 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.74149651 |
| 158 | MP0001851_eye_inflammation | 0.74124460 |
| 159 | MP0001845_abnormal_inflammatory_respons | 0.73614086 |
| 160 | MP0004885_abnormal_endolymph | 0.73340538 |
| 161 | MP0010630_abnormal_cardiac_muscle | 0.73217374 |
| 162 | MP0001756_abnormal_urination | 0.73183720 |
| 163 | MP0001501_abnormal_sleep_pattern | 0.72226231 |
| 164 | MP0002006_tumorigenesis | 0.71981793 |
| 165 | MP0008569_lethality_at_weaning | 0.71505824 |
| 166 | MP0005319_abnormal_enzyme/_coenzyme | 0.70884225 |
| 167 | MP0004043_abnormal_pH_regulation | 0.70578498 |
| 168 | MP0009643_abnormal_urine_homeostasis | 0.70299571 |
| 169 | MP0008438_abnormal_cutaneous_collagen | 0.69843966 |
| 170 | MP0001958_emphysema | 0.66661903 |
| 171 | MP0005248_abnormal_Harderian_gland | 0.66558937 |
| 172 | MP0005464_abnormal_platelet_physiology | 0.63577162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.71324473 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 3.55347783 |
| 3 | Disinhibition (HP:0000734) | 3.45631499 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.31757209 |
| 5 | Optic neuritis (HP:0100653) | 3.31757209 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.21009718 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.21009718 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.20776595 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.09778345 |
| 10 | Cerebral aneurysm (HP:0004944) | 3.05948591 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99404017 |
| 12 | Amyotrophic lateral sclerosis (HP:0007354) | 2.96384574 |
| 13 | Inappropriate behavior (HP:0000719) | 2.88438863 |
| 14 | Orchitis (HP:0100796) | 2.82206799 |
| 15 | Thyroid carcinoma (HP:0002890) | 2.77637370 |
| 16 | Deep venous thrombosis (HP:0002625) | 2.68014141 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 2.67302212 |
| 18 | Agnosia (HP:0010524) | 2.63593129 |
| 19 | Macroorchidism (HP:0000053) | 2.59527211 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 2.58936451 |
| 21 | Stomatitis (HP:0010280) | 2.56393663 |
| 22 | Myocardial infarction (HP:0001658) | 2.55194975 |
| 23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.53135128 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49878196 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49878196 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49878196 |
| 27 | Myositis (HP:0100614) | 2.47761810 |
| 28 | Keratoconjunctivitis (HP:0001096) | 2.45294735 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 2.44881734 |
| 30 | Absent/shortened dynein arms (HP:0200106) | 2.43556965 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.43556965 |
| 32 | Abnormal pancreas size (HP:0012094) | 2.40307193 |
| 33 | Hematochezia (HP:0002573) | 2.36595231 |
| 34 | Aneurysm (HP:0002617) | 2.35962160 |
| 35 | Enlarged penis (HP:0000040) | 2.35088872 |
| 36 | Long toe (HP:0010511) | 2.34337006 |
| 37 | Febrile seizures (HP:0002373) | 2.31692727 |
| 38 | Increased CSF protein (HP:0002922) | 2.30596237 |
| 39 | Action tremor (HP:0002345) | 2.29245529 |
| 40 | Global brain atrophy (HP:0002283) | 2.29079693 |
| 41 | Recurrent skin infections (HP:0001581) | 2.28534902 |
| 42 | Volvulus (HP:0002580) | 2.28463052 |
| 43 | Mutism (HP:0002300) | 2.28094312 |
| 44 | Striae distensae (HP:0001065) | 2.27295595 |
| 45 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27159836 |
| 46 | Papilledema (HP:0001085) | 2.24914115 |
| 47 | Aortic aneurysm (HP:0004942) | 2.24808240 |
| 48 | Blue irides (HP:0000635) | 2.24214739 |
| 49 | Abnormality of the fovea (HP:0000493) | 2.23832609 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.20717939 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20156402 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20156402 |
| 53 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.19972637 |
| 54 | Frequent falls (HP:0002359) | 2.19808579 |
| 55 | Absent frontal sinuses (HP:0002688) | 2.19089349 |
| 56 | Dysmetric saccades (HP:0000641) | 2.18782789 |
| 57 | Iris hypopigmentation (HP:0007730) | 2.18439692 |
| 58 | Excessive salivation (HP:0003781) | 2.16453672 |
| 59 | Albinism (HP:0001022) | 2.16184432 |
| 60 | T lymphocytopenia (HP:0005403) | 2.15191955 |
| 61 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.14117175 |
| 62 | Visual hallucinations (HP:0002367) | 2.13636063 |
| 63 | Ocular albinism (HP:0001107) | 2.13371640 |
| 64 | Osteomalacia (HP:0002749) | 2.12995824 |
| 65 | Generalized hypopigmentation (HP:0007513) | 2.11780622 |
| 66 | Gaze-evoked nystagmus (HP:0000640) | 2.11646392 |
| 67 | Mitral valve prolapse (HP:0001634) | 2.11360448 |
| 68 | Hyperkalemia (HP:0002153) | 2.11020622 |
| 69 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.10983581 |
| 70 | Hypoplasia of the fovea (HP:0007750) | 2.10983581 |
| 71 | Xanthomatosis (HP:0000991) | 2.10378730 |
| 72 | Drooling (HP:0002307) | 2.09665071 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08519159 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.06358503 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.06358503 |
| 76 | Abnormal hair whorl (HP:0010721) | 2.04966099 |
| 77 | Polycythemia (HP:0001901) | 2.04564522 |
| 78 | Subacute progressive viral hepatitis (HP:0006572) | 2.00649889 |
| 79 | Heterotopia (HP:0002282) | 1.99952238 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 1.99926442 |
| 81 | Abnormality of T cell number (HP:0011839) | 1.98413437 |
| 82 | Difficulty running (HP:0009046) | 1.98097887 |
| 83 | Hyperglycemia (HP:0003074) | 1.97853518 |
| 84 | Postural instability (HP:0002172) | 1.97351761 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 1.96939752 |
| 86 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.96272129 |
| 87 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.96272129 |
| 88 | Protruding tongue (HP:0010808) | 1.96025877 |
| 89 | Hemiplegia (HP:0002301) | 1.95374290 |
| 90 | Goiter (HP:0000853) | 1.94627698 |
| 91 | Arterial tortuosity (HP:0005116) | 1.91876685 |
| 92 | Hypoalphalipoproteinemia (HP:0003233) | 1.91704103 |
| 93 | Alveolar cell carcinoma (HP:0006519) | 1.90795795 |
| 94 | Achilles tendon contracture (HP:0001771) | 1.89597103 |
| 95 | Esophageal varix (HP:0002040) | 1.88992481 |
| 96 | Hand muscle atrophy (HP:0009130) | 1.88133488 |
| 97 | Resting tremor (HP:0002322) | 1.88082678 |
| 98 | Hyperventilation (HP:0002883) | 1.87172471 |
| 99 | Abnormal ciliary motility (HP:0012262) | 1.87171826 |
| 100 | Complement deficiency (HP:0004431) | 1.87017759 |
| 101 | Chronic bronchitis (HP:0004469) | 1.86949831 |
| 102 | Hypoglycemic coma (HP:0001325) | 1.86679167 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 1.86241922 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.85944642 |
| 105 | Gingivitis (HP:0000230) | 1.85622645 |
| 106 | Mucopolysacchariduria (HP:0008155) | 1.84767339 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84767339 |
| 108 | Supranuclear gaze palsy (HP:0000605) | 1.84752544 |
| 109 | Truncal obesity (HP:0001956) | 1.84745098 |
| 110 | Recurrent fungal infections (HP:0002841) | 1.84123803 |
| 111 | Skin nodule (HP:0200036) | 1.83660369 |
| 112 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.83541641 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 1.83182869 |
| 114 | Gonadotropin excess (HP:0000837) | 1.83075919 |
| 115 | Widely spaced teeth (HP:0000687) | 1.83064660 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 1.82893826 |
| 117 | White forelock (HP:0002211) | 1.82849543 |
| 118 | Genetic anticipation (HP:0003743) | 1.81366445 |
| 119 | Rhinitis (HP:0012384) | 1.81069724 |
| 120 | Polyphagia (HP:0002591) | 1.80823286 |
| 121 | Neurofibrillary tangles (HP:0002185) | 1.80283384 |
| 122 | Abnormality of the lower motor neuron (HP:0002366) | 1.79923607 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79515275 |
| 124 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.79150547 |
| 125 | Impaired vibratory sensation (HP:0002495) | 1.78884015 |
| 126 | Hypoglycemic seizures (HP:0002173) | 1.78122738 |
| 127 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78105546 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77491351 |
| 129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77491351 |
| 130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77491351 |
| 131 | Lymphangioma (HP:0100764) | 1.77469515 |
| 132 | Asplenia (HP:0001746) | 1.76222270 |
| 133 | Mitral stenosis (HP:0001718) | 1.75612029 |
| 134 | Loss of speech (HP:0002371) | 1.75054888 |
| 135 | Bronchiectasis (HP:0002110) | 1.74903293 |
| 136 | Vascular tortuosity (HP:0004948) | 1.73256503 |
| 137 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.72616807 |
| 138 | Ketoacidosis (HP:0001993) | 1.72174052 |
| 139 | Focal seizures (HP:0007359) | 1.72139546 |
| 140 | Abnormality of the periventricular white matter (HP:0002518) | 1.71960956 |
| 141 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71703122 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.71027914 |
| 143 | Bundle branch block (HP:0011710) | 1.70815976 |
| 144 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.70788827 |
| 145 | Asymmetric septal hypertrophy (HP:0001670) | 1.69924273 |
| 146 | Pulmonary infiltrates (HP:0002113) | 1.69622548 |
| 147 | Recurrent sinusitis (HP:0011108) | 1.68619362 |
| 148 | Intrahepatic cholestasis (HP:0001406) | 1.68469641 |
| 149 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.68453220 |
| 150 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.67662206 |
| 151 | Milia (HP:0001056) | 1.67514881 |
| 152 | Exercise-induced muscle cramps (HP:0003710) | 1.67288555 |
| 153 | Narrow palate (HP:0000189) | 1.67081695 |
| 154 | Epidermoid cyst (HP:0200040) | 1.67034452 |
| 155 | Turricephaly (HP:0000262) | 1.66230727 |
| 156 | Exercise-induced myalgia (HP:0003738) | 1.65801667 |
| 157 | Termporal pattern (HP:0011008) | 1.65251426 |
| 158 | Insidious onset (HP:0003587) | 1.65251426 |
| 159 | Increased cerebral lipofuscin (HP:0011813) | 1.63099596 |
| 160 | EMG: neuropathic changes (HP:0003445) | 1.62381790 |
| 161 | Cerebral inclusion bodies (HP:0100314) | 1.60585525 |
| 162 | Dilatation of the ascending aorta (HP:0005111) | 1.58129293 |
| 163 | Rectal prolapse (HP:0002035) | 1.57790694 |
| 164 | Ventricular fibrillation (HP:0001663) | 1.57246983 |
| 165 | Papillary thyroid carcinoma (HP:0002895) | 1.56704759 |
| 166 | Hyperacusis (HP:0010780) | 1.56087697 |
| 167 | Increased connective tissue (HP:0009025) | 1.55144593 |
| 168 | Dysostosis multiplex (HP:0000943) | 1.54279935 |
| 169 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.54093468 |
| 170 | Elfin facies (HP:0004428) | 1.52827933 |
| 171 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.50858515 |
| 172 | Thin bony cortex (HP:0002753) | 1.50713252 |
| 173 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.50020324 |
| 174 | Status epilepticus (HP:0002133) | 1.49935647 |
| 175 | Abnormality of the fingertips (HP:0001211) | 1.49787931 |
| 176 | Ketosis (HP:0001946) | 1.49674402 |
| 177 | Neuronal loss in central nervous system (HP:0002529) | 1.49379885 |
| 178 | Neoplasm of the heart (HP:0100544) | 1.49321431 |
| 179 | Gout (HP:0001997) | 1.48729714 |
| 180 | Lower limb amyotrophy (HP:0007210) | 1.48582011 |
| 181 | Intention tremor (HP:0002080) | 1.48494068 |
| 182 | Osteolytic defects of the hand bones (HP:0009699) | 1.48171415 |
| 183 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.48171415 |
| 184 | Coarse hair (HP:0002208) | 1.47946829 |
| 185 | Urinary urgency (HP:0000012) | 1.47685913 |
| 186 | Male infertility (HP:0003251) | 1.47390358 |
| 187 | Focal segmental glomerulosclerosis (HP:0000097) | 1.47024372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.55141639 |
| 2 | TRIB3 | 3.12122410 |
| 3 | RIPK1 | 2.62183382 |
| 4 | LATS1 | 2.58921113 |
| 5 | TNIK | 2.28484965 |
| 6 | MAP3K9 | 2.22478777 |
| 7 | MAP3K2 | 2.22353582 |
| 8 | PKN2 | 2.20703088 |
| 9 | KSR2 | 2.18576561 |
| 10 | PNCK | 1.90499979 |
| 11 | STK24 | 1.90341021 |
| 12 | CAMK1G | 1.87003704 |
| 13 | CAMK1D | 1.86491106 |
| 14 | ERN1 | 1.85381028 |
| 15 | TAOK3 | 1.84512506 |
| 16 | PRKD3 | 1.82836363 |
| 17 | CDK12 | 1.82753730 |
| 18 | FRK | 1.82566073 |
| 19 | YES1 | 1.72454543 |
| 20 | AKT3 | 1.71674994 |
| 21 | PTK6 | 1.64343706 |
| 22 | STK38 | 1.58006030 |
| 23 | RET | 1.56673717 |
| 24 | CAMKK1 | 1.54877464 |
| 25 | TTN | 1.53807886 |
| 26 | FGR | 1.52625413 |
| 27 | PDGFRA | 1.51735219 |
| 28 | CDK19 | 1.51433511 |
| 29 | PIK3CG | 1.51254584 |
| 30 | SIK1 | 1.51167978 |
| 31 | NTRK3 | 1.50550485 |
| 32 | PAK6 | 1.44500490 |
| 33 | TAOK1 | 1.43609074 |
| 34 | BLK | 1.43384271 |
| 35 | INSRR | 1.37905854 |
| 36 | LATS2 | 1.37555212 |
| 37 | SIK2 | 1.35173001 |
| 38 | BCR | 1.35160492 |
| 39 | MAP2K4 | 1.31844268 |
| 40 | SCYL2 | 1.31722313 |
| 41 | MAP3K7 | 1.31306265 |
| 42 | MAP3K4 | 1.30949679 |
| 43 | NTRK1 | 1.30315370 |
| 44 | TRIM28 | 1.26104820 |
| 45 | NLK | 1.25819604 |
| 46 | LMTK2 | 1.24484359 |
| 47 | JAK1 | 1.24350793 |
| 48 | DMPK | 1.24332522 |
| 49 | FGFR3 | 1.23887901 |
| 50 | PLK2 | 1.23622906 |
| 51 | PRKCH | 1.23338868 |
| 52 | RIPK4 | 1.21327840 |
| 53 | MAP3K14 | 1.20769364 |
| 54 | BRD4 | 1.20267643 |
| 55 | KSR1 | 1.17780755 |
| 56 | MAP3K13 | 1.17175297 |
| 57 | ERBB3 | 1.15377657 |
| 58 | PDGFRB | 1.12428386 |
| 59 | SGK3 | 1.10204859 |
| 60 | STK38L | 1.09684919 |
| 61 | SGK494 | 1.07069597 |
| 62 | SGK223 | 1.07069597 |
| 63 | MAP3K1 | 1.03404952 |
| 64 | PTK2 | 1.03222293 |
| 65 | WNK1 | 1.02485472 |
| 66 | MKNK2 | 1.02211028 |
| 67 | CDK6 | 1.02083217 |
| 68 | HIPK2 | 0.99496136 |
| 69 | OXSR1 | 0.98468029 |
| 70 | MATK | 0.97907087 |
| 71 | WNK3 | 0.97324422 |
| 72 | SIK3 | 0.95770150 |
| 73 | IRAK4 | 0.94280568 |
| 74 | BMPR2 | 0.92852981 |
| 75 | BMPR1B | 0.90634017 |
| 76 | PDPK1 | 0.89573448 |
| 77 | PDK1 | 0.88705913 |
| 78 | JAK2 | 0.87604106 |
| 79 | IRAK1 | 0.86041894 |
| 80 | STK3 | 0.85919477 |
| 81 | TGFBR2 | 0.84004592 |
| 82 | EPHB1 | 0.83731331 |
| 83 | FER | 0.83681196 |
| 84 | DAPK2 | 0.83626380 |
| 85 | FGFR4 | 0.82847167 |
| 86 | ALK | 0.81103011 |
| 87 | PAK3 | 0.79212194 |
| 88 | MAP3K10 | 0.78751530 |
| 89 | LRRK2 | 0.78423486 |
| 90 | DYRK1A | 0.72612506 |
| 91 | BMX | 0.72607051 |
| 92 | CSF1R | 0.70058037 |
| 93 | EEF2K | 0.70008312 |
| 94 | NEK1 | 0.69937163 |
| 95 | MAP3K6 | 0.69884591 |
| 96 | CAMKK2 | 0.69662135 |
| 97 | TYRO3 | 0.69036876 |
| 98 | TEC | 0.68976914 |
| 99 | MARK2 | 0.68285485 |
| 100 | STK10 | 0.67155043 |
| 101 | MTOR | 0.67022931 |
| 102 | CAMK1 | 0.65238069 |
| 103 | TAF1 | 0.65204580 |
| 104 | SGK2 | 0.63930900 |
| 105 | STK11 | 0.63617174 |
| 106 | PRKAA1 | 0.63569162 |
| 107 | IKBKE | 0.62613632 |
| 108 | FES | 0.61645516 |
| 109 | FGFR2 | 0.61498685 |
| 110 | MINK1 | 0.60680852 |
| 111 | MARK3 | 0.58631317 |
| 112 | MAPK7 | 0.57855385 |
| 113 | SYK | 0.57293914 |
| 114 | PRKAA2 | 0.57211298 |
| 115 | PRKCQ | 0.57008136 |
| 116 | SGK1 | 0.54441736 |
| 117 | PTK2B | 0.53833556 |
| 118 | PRPF4B | 0.53228741 |
| 119 | PINK1 | 0.53034228 |
| 120 | JAK3 | 0.52550365 |
| 121 | MAP2K1 | 0.51841708 |
| 122 | DYRK3 | 0.50787646 |
| 123 | * PRKD1 | 0.50362912 |
| 124 | PDK3 | 0.50104515 |
| 125 | PDK4 | 0.50104515 |
| 126 | HCK | 0.49742656 |
| 127 | ABL1 | 0.49740028 |
| 128 | MAPK10 | 0.49608990 |
| 129 | MELK | 0.48850935 |
| 130 | LYN | 0.48735997 |
| 131 | EGFR | 0.48490373 |
| 132 | NEK9 | 0.48226100 |
| 133 | CASK | 0.48221698 |
| 134 | RAF1 | 0.47784551 |
| 135 | CDC42BPA | 0.47541355 |
| 136 | TYK2 | 0.47070303 |
| 137 | PRKD2 | 0.46997077 |
| 138 | PRKCE | 0.46242300 |
| 139 | MKNK1 | 0.45209765 |
| 140 | KIT | 0.44837746 |
| 141 | NEK6 | 0.44267078 |
| 142 | CDK5 | 0.43257966 |
| 143 | MUSK | 0.42843704 |
| 144 | MAP3K3 | 0.42819134 |
| 145 | RPS6KA3 | 0.42207126 |
| 146 | EPHA4 | 0.42098024 |
| 147 | CSK | 0.41727617 |
| 148 | MAPK12 | 0.41431313 |
| 149 | RPS6KA2 | 0.41209767 |
| 150 | MAP3K5 | 0.38705252 |
| 151 | TRPM7 | 0.35937871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25980384 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74696901 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65029313 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 1.63567811 |
| 5 | Tuberculosis_Homo sapiens_hsa05152 | 1.58174161 |
| 6 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58104494 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52386469 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.51027298 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47816681 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44398404 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41884096 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38726005 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.36293929 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.33074788 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30777091 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28921135 |
| 17 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.27575399 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25895440 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.25025987 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24532720 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22678266 |
| 22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.21849876 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.18097556 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17159890 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.16633695 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16072561 |
| 27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14866439 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.14690627 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13239206 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11213998 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.10303543 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.09515574 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06292162 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06175592 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04517998 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04451896 |
| 37 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.03933001 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03656892 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03307830 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.02940006 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00859718 |
| 42 | Glioma_Homo sapiens_hsa05214 | 0.98839065 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98656240 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 0.98206627 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97986995 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 0.97487386 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97418187 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96245192 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95042756 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.94976903 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93678336 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92566322 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91705565 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90045046 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89456379 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89265099 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87986590 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86454373 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86009687 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85366158 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85214126 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85205692 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84608162 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83914479 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83375516 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82605415 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82168330 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.82083933 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81634336 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81294133 |
| 71 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80826816 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.80337806 |
| 73 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79200906 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78751602 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.77791663 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77254232 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77235559 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.76798983 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76639859 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76424967 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76240516 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76081040 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75112149 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.74318329 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73935903 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73862433 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73757369 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73472517 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73169383 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72531206 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72434545 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71736351 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71704536 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.71651479 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.71517811 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71127152 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70616004 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.70291246 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69890734 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69356609 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68764381 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67733929 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67549312 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66740895 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65772696 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65744545 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.65352009 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65059155 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.64937068 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64536974 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64089375 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63314829 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63227525 |
| 114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62826018 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62515201 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61985380 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61618818 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61418307 |
| 119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61028147 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60778550 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59933519 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59397146 |
| 123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59179772 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.59054564 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57563902 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57155374 |
| 127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57017405 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56843088 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56809028 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55713038 |
| 131 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55709398 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.55426395 |
| 133 | Morphine addiction_Homo sapiens_hsa05032 | 0.55215522 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55142140 |
| 135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54716856 |
| 136 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54460063 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54142827 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53454450 |
| 139 | Long-term depression_Homo sapiens_hsa04730 | 0.53379456 |
| 140 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52965735 |
| 141 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52942174 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52701083 |
| 143 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52590870 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52590619 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.52467412 |
| 146 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52361820 |
| 147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51974730 |

